Medical conditions at enrollment do not impact efficacy and safety of the adjuvanted recombinant zoster vaccine: a pooled post-hoc analysis of two parallel randomized trials

  1. Oostvogels, L.
  2. Heineman, T.C.
  3. Johnson, R.W.
  4. Levin, M.J.
  5. McElhaney, J.E.
  6. Van den Steen, P.
  7. Zahaf, T.
  8. Dagnew, A.F.
  9. Chlibek, R.
  10. Diez-Domingo, J.
  11. Gorfinkel, I.S.
  12. Hervé, C.
  13. Hwang, S.-J.
  14. Ikematsu, H.
  15. Kalema, G.
  16. Lal, H.
  17. McNeil, S.A.
  18. Mrkvan, T.
  19. Pauksens, K.
  20. Smetana, J.
  21. Watanabe, D.
  22. Weckx, L.Y.
  23. Cunningham, A.L.
Journal:
Human Vaccines and Immunotherapeutics

ISSN: 2164-554X 2164-5515

Year of publication: 2019

Volume: 15

Issue: 12

Pages: 2865-2872

Type: Article

DOI: 10.1080/21645515.2019.1627818 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals